{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:32:36Z","timestamp":1777944756580,"version":"3.51.4"},"reference-count":9,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Womens Health (Lond Engl)"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:p>Ulipristal acetate was investigated in four phase 3 trials. In PEARL I, ulipristal produced significant normalisation of blood loss within 1 week and decreased fibroid volume. In PEARL II, ulipristal produced faster and more consistent control of bleeding than leuprorelin acetate and had a more favourable side-effect profile. Ulipristal-induced decreases in fibroid volume persisted for 6 months, whereas fibroids regrew after leuprorelin was stopped. PEARL III showed that ulipristal was effective during long-term treatment, with norethisterone further reducing the magnitude of bleeding in the off-treatment period. PEARL IV investigated ulipristal over four cycles, finding little difference between 5 and 10 mg ulipristal, further changes in menstruation and fibroid volume with repeat courses, and no increase in side effects.<\/jats:p>","DOI":"10.1177\/1745505717692591","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T03:38:20Z","timestamp":1486957100000},"page":"544-548","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":15,"title":["Esmya\n                    <sup>\u00ae<\/sup>\n                    and the PEARL studies: A review"],"prefix":"10.1177","volume":"12","author":[{"given":"Martin","family":"Powell","sequence":"first","affiliation":[{"name":"CircleNottingham, Nottingham NHS Treatment Centre, Nottingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborata","family":"Dutta","sequence":"additional","affiliation":[{"name":"Nottingham University Hospitals, Nottingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2017,2,13]]},"reference":[{"key":"bibr1-1745505717692591","unstructured":"Gedeon Richter (UK) Ltd. Summary of product characteristics: Esmya 5 mg tablets (ulipristal acetate), www.medicines.org.uk\/emc\/medicine\/26068 (2016, accessed 15 June 2016)."},{"key":"bibr2-1745505717692591","volume":"44","author":"National Institute for Health and Care Excellence","year":"2016","journal-title":"NICE Clin Guidel"},{"key":"bibr3-1745505717692591","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.04.025"},{"key":"bibr4-1745505717692591","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103182"},{"key":"bibr5-1745505717692591","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103180"},{"key":"bibr6-1745505717692591","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.02.008"},{"key":"bibr7-1745505717692591","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.10.038"},{"key":"bibr8-1745505717692591","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.09.032"},{"key":"bibr9-1745505717692591","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(87)91074-8"}],"container-title":["Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1745505717692591","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1745505717692591","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1745505717692591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T08:24:22Z","timestamp":1777710262000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1745505717692591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1177\/1745505717692591"],"URL":"https:\/\/doi.org\/10.1177\/1745505717692591","relation":{},"ISSN":["1745-5057","1745-5065"],"issn-type":[{"value":"1745-5057","type":"print"},{"value":"1745-5065","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}